Diabetic Retinopathy

Over time, high blood sugars can cause damage to retinal vessels and vision loss from diabetic retinopathy.

What is Diabetes Mellitus?

Diabetes is commonly known as elevated blood sugar. It occurs in young people who have trouble producing a substance called insulin that regulates blood sugar, as well as in older people who develop resistance to insulin as they age. Young diabetics are often referred to as Type 1, while older diabetics are ofte referred to as Type 2. There are also some diabetics who exhibit characteristics of both Type 1 and Type 2 diabetes. All types of diabetics suffer similar effects of elevated blood sugar.
When diabetes is uncontrolled it damages blood vessels throughout the body. The longer a person is diabetic and the more poorly the blood sugar levels are controlled, the more likely that person is to suffer blood vessel damage. As diabetes worsens, it first affects the smallest blood vessels, called capillaries, throughout the body. Some of the locations in the body where tiny capillaries are the most important include the kidneys, the nerves in the legs, feet, and hands, and in the light-sensing tissue of the eye called the retina.

What is Diabetic Retinopathy?

The earliest sign of small blood vessel damage in the retina is background diabetic retinopathy, also known as non-proliferative diabetic retinopathy. Background diabetic retinopathy occurs as small blood vessel disease becomes visible in the retina, and your eye doctor can see small aneurysms or hemorrhages (also known as "blood spots") in the retinal tissue at this stage. Most diabetics with background diabetic retinopathy do not know that they have this sign of advancing diabetes, since it does not always affect the vision when it is mildly or moderately severe. However, early detection of background diabetic retinopathy is crucial, as it helps the patient's primary care doctor or endocrinologist (diabetic disease specialist) know the status of the diabetic blood vessel damage throughout the body. The diagnosis of background diabetic retinopathy also lets the patient's eye doctor know that the patient is at a higher risk of vision loss than a patient without background diabetic retinopathy. The guidelines of the American Diabetes Association and American Academy of Ophthalmology reflect that all diabetics should have a dilated eye exam regularly in an effort to detect background diabetic retinopathy while it is still in its early stages.

What is a Diabetic Eye Examination?

When a patient comes to the retinal office for a diabetic eye exam, there are sometimes special imaging tests recommended by the doctor in addition to the dilated eye exam. These tests can include specific pictures of the eye with both regular color digital cameras and special laser cameras. Retinal tomography, or an evaluation of the retinal thickness and the retinal layers, is a unique technology often used to assess the structure and health of the diabetic retina. Fluorescein angiography is another specialized imaging test that allows for detailed visualization of the tiny retinal blood vessels as well as leakage from areas that are diseased. Sometimes an ultrasonic picture of the back of the eye is obtained. During your visit, your doctor will decide which of these tests are important for assessment of the retina. Not every test is recommended at every visit.

What can I do to Preserve Vision?

The cornerstone of saving vision in diabetes remains excellent blood sugar control. Over the last 2 generations, there has been ample, repeated evidence that keeping the blood sugar at an appropriate level, controlling blood pressure, and monitoring cholesterol and fats in the blood are the most effective ways to stave off diabetic retinopathy. It is very important that every diabetic has a good relationship with their primary care team and makes every effort to optimize their diabetic health. A healthy diet, regular exercise several times each week, routine at-home blood sugar monitoring as directed by your diabetic doctor, and ongoing compliance with diabetic medications are the most important part of saving vision in diabetes.

What is Background Diabetic Retinopathy?

If diabetes remains poorly controlled, background diabetic retinopathy advances as there is more and more small blood vessel damage. The small blood vessels continue to collapse and result is varying degrees of retinal ischemia, or poor blood flow to the retinal tissue due to the absence of normal blood vessel supply. Essentially, progressing diabetic retinopathy is like placing a tourniquet on the retina a slowly tightening it. There is currently no technology to restore the lost blood vessels. The lack of these blood vessels itself can cause irreversible vision loss and often limits the vision in diabetics.

What is Diabetic Macular Edema?

, There are two treatable processes that occur as there is less and less normal retinal blood flow. The first is called diabetic macular edema, which means swelling in the retina associated with diabetes. This swelling can blur and distort the vision. The swelling occurs because the walls of the small blood vessels are progressively more damaged in diabetes, and there is leakage of blood and fluid into the cells of the retina.

Read more

What is Proliferative Diabetic Retinopathy?

The second treatable process in diabetic retinopathy is the growth of abnormal new blood vessels in the eye. This process is called proliferative retinopathy. The abnormal new blood vessels in the eye probably appear in response to progressive absence of normal blood vessels, and this is an even more ominous process than diabetic macular edema. Often there is both diabetic macular edema and proliferative diabetic retinopathy in the same patient at the same time. The abnormal new blood vessels seen in proliferative retinopathy are fragile and often will bleed into the vitreous jelly filling the back of the eye. This process is called vitreous hemorrhage, and patients will often see hundreds of spots, swirls, or lines when vitreous hemorrhage begins. Sometimes the hemorrhage can be so dense that there is severe blurring of vision. As the abnormal new blood vessels continue to grow, they get denser and thicker. This process can lead to tugging or traction on the retina, and that is termed a diabetic tractional retinal detachment. Diabetic retinal detachment is the most serious and advanced stage of diabetic retinopathy. Abnormal new blood vessel growth in the eye can be treated in its earlier stages with laser therapy. The laser technique is much different than that applied to diabetic macular edema.

Read more

What is a Vitreous Hemorrhage?

Patients with diabetes develop weak blood vessels in the retina that are prone to bleeding. If bleeding occurs into the vitreous cavity, patients will see many tiny floaters and develop moderate to severe vision loss. The blood inside the eye doesn't harm the eye but it does block the vision. Blood inside the eye will sometimes absorb within a few weeks or months. When the blood absorb the vision improves. If the blood doesn't asborb, vitrecotmy surgery can be performed to improve the vision. Because of the risk of surgery, most surgeons wait anywhwere from one month to 6 months depending on the situation to see if the blood will clear without surgery.

Read more

What is a Diabetic Tractional Retinal Detachment?

Patients with proliferative diabetic retinopathy sometimes develop a tractional retinal detachment. This can occur when scar tissue grows on the surface of the retina and then contracts or is pulled forwward in the eye by the vitreous. When this happens, the retina, which is stuck to the diabetic scar tissue, pulls away from the back of the eye and away from its blood supply. The vision declines and the retina suffers. Tractional retinal detachments can usually be prevented if sufficient pan-retinal laser is administered before the scar tissue progresses. Once there is a tractional retinal detachment surgery can be helpful.

Read more

Diabetic Retinopathy NEWS

Below are current articles from a Google News Feed on Diabetic Retinopathy

Analysis of Patient-Reported Barriers to Diabetic Retinopathy Follow-Up  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVES:Close follow-up of diabetic retinopathy (DR) has been linked to improved ...

Diabetic Retinopathy: 2-Year Screening Interval May Be Okay  Medscape

People with diabetes who have minimal or no retinopathy at initial screening are unlikely to progress to the point of requiring retinopathy treatment within 2 years ...

Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVE:To quantify the size and location of nonperfusion associated with posterior ...

How hospitals in India are helping Alphabet's AI project for diabetic retinopathy  Becker's Hospital Review

Hospitals in India are helping Alphabet build an artificial intelligence algorithm that screens patients for diabetic retinopathy.

More Diabetic Retinopathy Screening? Primary Care May Be the Answer  MedPage Today

Primary care may be an untapped resource for diabetic retinopathy screening, a new study suggested. In a survey of over 3,200 adults with diabetes, nearly 88% ...

Statins May Reduce Risk of Retinopathy in Diabetes Patients  MD Magazine

Statins are already a common therapy among patients with type 2 diabetes. Its cholesterol-lowering benefits may help retain patient vision longer.

New Retinal Scanner Helps Diagnose Diabetic Retinopathy  The Parsons Advocate

ELKINS, W.Va. – A new technology at Davis Medical Center (DMC) is designed to help those with diabetes detect diabetic retinopathy in its early stages and ...

Identifying Early Stages Of Diabetic Retinopathy With Google's AI  Healthcare Tech Outlook

More than 400 million people have diabetes today. Due to several external and internal factors including hereditary and lifestyle, individuals tend to suffer...

Intervention for diabetic retinopathy | JAMA Ophthalmology  MD Linx

Internal Medicine Article: Two-year incidence of retinal intervention in patients with minimal or no diabetic retinopathy on telemedicine screening.

Can AI Detect Diabetic Retinopathy More Accurately?  Diabetes In Control

Automatic information processing studied to help find diabetic retinopathy on a larger scale. Lately, Convolutional Neural Networks (CNNs) have been used to ...

Diabetic Retinopathy Market Growth Opportunity and Industry Revenue Analysis by Major Players, 2014-2022 |  Medgadget

The Global Diabetic Retinopathy Market generated $966 million in 2015 and is projected to attain $2.5 billion by 2022, registering a CAGR of 14.4% during.

Diabetes Eye Exam Frequency in US Is 'Alarmingly Low'  Medscape

The frequency of eye exams among insured patients with type 1 and type 2 diabetes in the United States is "alarmingly low," new research indicates. Findings ...

Diabetic Retinopathy – Research and Epidemiology Forecast to 2028  Nevada Green Times

Diabetic Retinopathy- Epidemiology Forecast To 2028– report provides a comprehensive analysis of the Diabetic retinopathy epidemiology, providing the ...

Regeneron (REGN) Announces 1-Yr. Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis Symposium  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Regeneron Pharmaceuticals, Inc. (NASDAQ: ...

Personalized risk -based diabetes retinopathy screening | Diabetes, Obesity and Metabolism  MD Linx

Internal Medicine Article: Personalized risk-based screening for diabetic retinopathy: A multivariate approach vs the use of stratification rules.

Incidence of sight-threatening diabetic retinopathy in T2DM | Diabetic Medicine  MD Linx

Internal Medicine Article: Incidence of sight-threatening diabetic retinopathy in people with type 2 diabetes mellitus and numbers needed to screen: A systematic ...

Diabetic Retinopathy Market Competitive Strategies and Global Demand 2019-2025  Eagle Chronicle

Global Diabetic Retinopathy Market report covers the segmentation arena, market secrets and regional retreats, size, share, growth analysis, trends and plans of ...

Walgreens and CVS are redesigning their drugstores to focus more on health. Here's how they compare  CNBC

As people shop online more, CVS and Walgreens are trying to give people reasons to keep coming into their stores.

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM  GlobeNewswire

BROSSARD, Quebec, Jan. 22, 2019 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Company”) (TSX Venture Exchange: ADK) (OTCQB: DGNOF), ...

Diabetes Patients Now Being Tested with AI in More Settings  PRNewswire

CORALVILLE, Iowa, Feb. 12, 2019 /PRNewswire/ -- A growing number of Americans with diabetes are now having their eyes checked for a leading cause of ...

Global Diabetic Retinopathy Market 2019 : Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals  Be Internet News

“The Brand New Global Diabetic Retinopathy Market Report 2019 Concentrates On Restraints, Reimbursement Policies, Technological Advancements, PEST ...

More Reasons To Use Statins For Diabetes Treatment  Diabetes In Control

Treatment with statins for diabetes associated with lower risks of major adverse cardiovascular events, retinopathy, neuropathy, and foot ulcers.

Take a Closer Look at Eye Exams  Contemporary Clinic

Bedside assessments provide key information about patient health and can serve as prevention tools for those at risk of falling.

8 Nutrients That Will Optimize Your Eye Health  BusinessGhana

Eye health goes hand-in-hand with general health, but a few nutrients are especially important for your eyes. These nutrients help maintain eye function, protect ...

Top News in Ophthalmology February 05 2019 (1 of 1)  MD Linx

A large portion of the US adult population with diabetes could be screened for diabetic retinopathy (DR) in primary care settings, including those at high risk of ...

Primary Care Settings Offer Opportunity for Wider Screening for Diabetic Retinopathy  MedicalResearch.com

MedicalResearch.com Interview with: Diane M. Gibson, Ph.D. Executive Director – New York Federal Statistical. Dr. Gibson. Diane M. Gibson, Ph.D. Executive ...

Rohan and Vallabh of Madison BMB Win IAA Contest to Build Awareness of Diabetic Retinopathy  Business Wire India

The International Advertising Association (IAA) India Chapter announced the winners for its campaign to build awareness of Diabetic Retinopathy in India. The.

Global Diabetic Retinopathy Market Industry Scenario Till 2027  Tech News Store

Global Diabetic Retinopathy Market 2018 report provides a global analysis of Diabetic Retinopathy market data from 2018 to 2027. The report reveals the ...

Statins May Prevent Diabetic Retinopathy in People with Diabetes  EndocrineWeb

Individuals with diabetes who were taking a statin for high blood cholesterol have the added benefit of reducing their risk of developing diabetic retinopathy, and ...

Patient-reported severity of dry eye and quality of life in diabetes | OPTH  Dove Medical Press

Md Kaosar Yazdani-Ibn-Taz,1 Myint Myint Han,1 Sven Jonuscheit,1 Andrew Collier,1,2 Jane E Nally,1 Suzanne Hagan1 1School of Health and Life Sciences, ...

Diet Soda Can Lead to Blindness for Diabetics  Newsmax

Drinking more than four cans of diet soda per week may cause a type of diabetic eye disease that leads to blindness, according to a study. The risk of developing ...

Global Diabetic Retinopathy Market Expected to Reach USD 9.3 Billion By 2024: Zion Market Research  Industry News Press

The “Diabetic Retinopathy Market – by Type (Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy) and by Management (Vitrectomy, ...

Bill from GA governor would expand public spending on health care, but critics say not by enough  SaportaReport

By Maggie Lee. The two-and-a-half-page bill that came out in the state Senate last week has big implications for hundreds of thousands of uninsured Georgians: ...

Eyenuk To Provide Artificial Intelligence (AI) Eye Screening to Thousands of Italians Through Collaboration With Ambrosian Ophthalmic Center in February  Business Wire

LOS ANGELES--(BUSINESS WIRE)--Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world ...

Proliferative Diabetic Retinopathy Market 2019: Global Key Players Intas Pharmaceuticals, Santen Pharmaceutical, Valeant Pharmaceuticals International  Buffalo Morning Star

Global Proliferative Diabetic Retinopathy Market Research Report 2018 from MarketAndResearch.biz offers a comprehensive study including company's ...

Taking too much sugar? Why your eyes may suffer  Daily Monitor

Diabetic eye disease is a group of eye conditions that affect people with diabetes due to unbalanced sugar levels in the body. It can affect many parts of the eye ...

Macular Degeneration (AMD) And Diabetic Retinopathy (DR) Drugs Market Clinical Analysis 2019  Nevada Green Times

Global Macular Degeneration (AMD) And Diabetic Retinopathy (DR) Drugs Market Size, Status And Forecast 2019-2025. The report provides a unique tool for ...

Diabetic Retinopathy Market 2019 – Therapeutic Survey, Epidemiology and Forecast till 2028  Market Biz Mail

Latest Industry Research Report On “Diabetic Retinopathy – Market Insight, Epidemiology And Market Forecast – 2028” in-depth analysis of the market state and ...

Diet Soda Linked to Increased Risk for Diabetic Retinopathy  Medscape

Diet soda, but not regular soda, was linked to increased risk for proliferative diabetic retinopathy, a study found; further studies are needed to confirm these ...

Diabetic Retinopathy Market Size, Analysis and Forecast up to 2025  Honest Version

Diabetes is a lifelong chronic disease caused by excessive levels of glucose in the blood mainly due to lack or insufficiency of insulin hormone to metabolize the ...

Proliferative Diabetic Retinopathy Market Growth Analysis by Key Manufacturer Merck KGaA, Cipla, Genentech  Fashion Herald

HTF MI recently introduced Global Proliferative Diabetic Retinopathy Market study with focused approach on market size & volumes by Application, Industry ...

Nalco-LV Prasad Eye Hospital opened in Angul  Daily Pioneer

Union Minister Dharmendra Pradhan inaugurated a state-of-the-art eye care facility, “Nalco- LV Prasad Eye Hospital”, at Kulda in Angul district on Monday.

Global 2019 Diabetic Retinopathy Market Insights, Epidemiology Forecast to 2028  Fashion Herald

This Report Provides overview of “Diabetic Retinopathy Market” 2018 in global region. Also elaborate Company Competition, Market demand, Regional ...

(2019-2028) Global Diabetic retinopathy Market Insights, Epidemiology  TOP Tribune

2019 Latest Report Titled on: “Diabetic retinopathy- Epidemiology Forecast to 2028“. Diabetic retinopathy Market – Report provides a complete understanding of ...

AI to facilitate early diagnosis of diabetic retinopathy  Medical Device Network

A team at RMIT University have developed an AI-based image processing technology for quick detection of diabetic retinopathy in its earliest stages.

NorthShore Health Center welcomes Dr. Audrey Dawson to the team  PortageLife

As one of the Region's leaders of providing comprehensive and affordable healthcare, NorthShore Health Center has expanded its optometry services with an ...

Statin Therapy Reduces Risk for Diabetic Retinopathy in Type 2 Diabetes  The Cardiology Advisor

HealthDay News - For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, ...

FDA Clears AI Device for Diabetic Retinopathy Diagnosis  DARKDaily.com - Laboratory News

FDA clearance of an AI system for diagnosing diabetic retinopathy using retinal images shows medical potential of deep learning and algorithmic analysis.

Diabetic retinopathy position statement promotes prevention, early detection, control  Healio

A new position statement by the American Diabetes Association recommends intensive glycemic control and regular screening for prevention and early ...

ICO Publishes New Guidelines for Diabetic Retinopathy  MD Magazine

Importantly, they are not directed toward ophthalmologists, but at general physicians and public healthcare professionals.

Diet soda consumption associated with increased risk of diabetic retinopathy  Healio

Researchers found that patients with diabetes who consumed more than four cans per week of a diet soft drink had a more-than-twofold risk of having ...

Statins Cut Retinopathy Risk in Type 2 Diabetes  MedPage Today

Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large ...

Diabetic Retinopathy Treatment Industry 2019 Research Report Forecast 2025  Big Times News

Global Diabetic Retinopathy Treatment Market research report is delivering key insights and providing a competitive advantage to clients through a detailed ...

Considering Three Major Developments in the Diabetes Retinopathy Industry  MD Magazine

The DR market is expected to accrue a sum of $2490 million by 2022, growing at a compound annual growth rate of 14.4% from 2014-2022.

Theratechnologies (TH) to Release Earnings on Thursday  Fairfield Current

Theratechnologies (TSE:TH) is set to release its earnings data before the market opens on Thursday, February 21st. Analysts expect Theratechnologies to post ...

DIABETIC RETINOPATHY- MARKET INSIGHT, EPIDEMIOLOGY AND MARKET FORECAST – 2028 MARKET DATA 2019: TYPE, SHARE, SEGMENTS, PATIENT POPULATION, TREATMENT APPROACHES, IMPACT OF UPCOMING THERAPIES FOR 2028  Honest Version

Global Diabetic Retinopathy- Market Insight, Epidemiology and Market Forecast – 2028 Market studies the present scenario of market (with the base year being ...

Ocular Surgery Market Product Overview, Development Prospect and Future Scenario 2019-2028  PharmiWeb.com

Blindness is mainly caused due to eye diseases which includes cataract, glaucoma, macular degeneration, diabetic retinopathy. People who suffer from ...

Diet Soda Associated with Increased Risk for Diabetic Retinopathy, Study  dLife.com

New findings show that drinking diet soda may increase the risk for proliferative diabetic retinopathy (PDR), a severe type of diabetic eye disease, according to ...

Two Treatments, Similar Outcomes in Diabetic Retinopathy  MedPage Today

Two different approaches to treating proliferative diabetic retinopathy (PDR) led to similar improvement in visual acuity at 5 years, results of a randomized trial ...

High Demand for Retinal Biologics Anticipated as Incidences of Diabetic Retinopathy Increase: FMI Survey  Future Market Insights

Retinal diseases are a significant concern among millions of people worldwide. According to the Centers for Disease Control and Prevention (CDC), around 1.8 ...

FDA to Review Injection Treatment for Diabetic Retinopathy  Pharmacy Times

The FDA has accepted for review Regeneron Pharmaceuticals' supplemental Biologics License Application (sBLA) of aflibercept (EYLEA Injection) to treat ...

Comparing of Nemaura Medical Inc. (NMRD) and IRIDEX Corporation (NASDAQ:IRIX)  The Hi New Ulm

Since Nemaura Medical Inc. (NASDAQ:NMRD) and IRIDEX Corporation (NASDAQ:IRIX) are part of the Medical Appliances & Equipment industry, they are ...

Global Diabetic retinopathy Market 2019 by Type, Share, Growth, Trends and Forecast To 2025  Bitcoin Journal

Mart research Diabetic retinopathy – Epidemiology Forecast, 2028 report provides a comprehensive analysis of the Diabetic retinopathy epidemiology, providing ...

Global Proliferative Diabetic Retinopathy Market Research Report 2019 to 2025: By Product, Application, Manufacturer, Sales and Segmentation  Cryptocurrency News

MarketResearchNest.com presents “Global Proliferative Diabetic Retinopathy Market Research Report 2019” new Research to its studies database.

Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Insights 2019-2025: Novartis, Bayer Healthcare, Roche  The Concepts News

The global “Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market” research report is crafted with the concise assessment and extensive ...

Using artificial intelligence to automate screening for diabetic retinopathy  Ophthalmology Times

A Deep Learning System (DLS) is an advanced form of artificial intelligence (AI) that can start with a mix of images from different groups and then learn to ...

Statins, Fibrates Lower Diabetic Retinopathy Risks in Diabetes  Medscape

The use of lipid-lowering medication with fibrates, including fenofibrate (Lipidil, Abbott), and statins reduces not only the incidence of diabetic retinopathy in ...

GLP-1 Receptor Agonists Not Associated With Increased Diabetic Retinopathy Risk  Endocrinology Advisor

Use of glucagon-like peptide 1 (GLP-1) receptor agonists does not increase risk for diabetic retinopathy in older adults, according to study results publis.

Study finds correlation between fish intake, diabetic retinopathy severity in Asian population  Healio

VIENNA — A significant association between fish intake and severity of diabetic retinopathy was found in a study carried out in Singapore. “Recently a favorable ...

Don't Let Diabetic Eye Disease Sneak Up on You  University of Utah Health Care

Nov 14, 2018 12:00 AM. If you are one of the 30.3 million Americans with diabetes, you are at risk for diabetic eye disease—including blindness.

AI System Gets Low Grade for Diagnosing Diabetic Retinopathy  MedPage Today

An artificial intelligence (AI) system designed to detect diabetic retinopathy did not perform well in a real-world clinical setting, Australian researchers reported.

GLP-1 Drugs Not Associated With Increased Risk of Diabetic Retinopathy, Study Finds  AJMC.com Managed Markets Network

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with increased risk of incident diabetic retinopathy, according to a study published in ...

Different risk factors predict diabetic retinopathy, nephropathy in type 2 diabetes  Healio

Progression of diabetic retinopathy is associated with increased HbA1c, whereas risk factors for diabetic nephropathy include HbA1c variability and dyslipidemia ...

FDA-approved AI diabetic retinopathy system able to make diagnoses in 20 seconds  Health Imaging

Research detailing the first FDA-approved artificial intelligence (AI) system to autonomously detect diabetic retinopathy was published Aug. 28 in Nature Digital ...

Benefits with Early Treatment of Diabetic Retinopathy  MedPage Today

VANCOUVER -- Almost 60% of patients with nonproliferative diabetic retinopathy (NPDR) had at least a two-step improvement in retinopathy score when treated ...

Zacks: Brokerages Expect Aerpio Pharmaceuticals, Inc. (ARPO) Will Post Earnings of -$0.18 Per Share  Fairfield Current

Equities research analysts expect Aerpio Pharmaceuticals, Inc. (NYSE:ARPO) to announce earnings per share of ($0.18) for the current quarter, Zacks reports.

In-Clinic Hurdles for AI-Based Diabetic Retinopathy Detection  Medscape

Researchers found mixed results when they tested an artificial intelligence (AI)‒based system for detecting diabetic retinopathy (DR) in a real-world primary ...

Oxurion NV to Present at the 2019 BIO CEO & Investor Conference  Associated Press

Leuven, Belgium, 4 February 2019 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision ...

Could ELOVL4 Expression be a Key to Preventing Diabetic Retinopathy?  MD Magazine

Diabetes causes ELOVL4 to be downregulated, weakening the tight junctions. Researchers hope that replacing these lipids could be a treatment for diabetic ...

Global Ophthalmic Drugs Market Size, Industry Status & Growth Opportunity  Tech News Store

Ophthalmic Drugs Market Report provides detailed insight, industry knowledge, market forecasts, and analytics. Report on Global Ophthalmic Drugs Industry ...

Global Proliferative Diabetic Retinopathy Market Study 2019 by Manufacturers Intas Pharmaceuticals, Santen Pharmaceutical, Allergan Plc  Crypto News

2019-2026 Proliferative Diabetic Retinopathy Market Report. Global Proliferative Diabetic Retinopathy Market report covers the present and future scenario and ...

Aflibercept Reverses Nonproliferative Diabetic Retinopathy Progression  MD Magazine

Intravitreal aflibercept injection showed early signs of activity for patients with moderately severe to severe nonproliferative diabetic retinopathy.

Skipping Treatment for Diabetic Retinopathy Carries Risks  Medscape

Drs Jason Hsu and Anthony Obeid on how the 25% of patients lost to follow-up are vulnerable to vision loss and other adverse outcomes.

FDA to Review Eylea for the Treatment of Non-Proliferative Diabetic Retinopathy - MPR  Monthly Prescribing Reference

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) of Eylea (aflibercept; Regeneron) for the ...

Diabetic Eye Exams: Why They Matter  Contemporary Clinic

Diabetes can result in vision problems, so it is important to closely monitor patients through comprehensive eye examinations. Unfortunately, diabetic eye ...

EYLEA® (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial  BioSpace

TARRYTOWN, N.Y., Oct. 25, 2018 /PRNewswire/ --. First trial in non-proliferative diabetic retinopathy to show both a reduction in vision-threatening ...

The worldwide epidemic of diabetic retinopathy  The New Times

There are about 422,000,000 million people living with diabetes worldwide, according to 2014 statistics by World Health Organisation (WHO). The number of ...

Diet Soda Linked to Risk for Diabetic Blindness  WebMD

Jan. 8, 2019 -- Drinking diet soda may raise the risk for a severe type of diabetic eye disease that can lead to blindness, a new study says. The study, published ...

Study identifies barriers and enablers of diabetic retinopathy screening  Medical Xpress

A new study, conducted as part of a NIHR-funded project on diabetic retinopathy screening, has identified important barriers, and enablers, associated with ...

Diabetic Retinopathy Telemedicine Screening Could Greatly Benefit Underserved Populations  MD Magazine

Telemedicine screenings provided by a primary care office in an urbanized setting over 2 years showed patients had an 81.9% compliance capture rate—a ...

Statin therapy reduces risk for diabetic retinopathy in T2DM  Medical Xpress

(HealthDay)—For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according ...

Anti-VEGF vs PRP for Proliferative Diabetic Retinopathy  Medscape

Diabetic retinopathy (DR) is a leading cause of vision loss and blindness among the adult population. Clinical manifestations of DR include microaneurysms, ...

Long-term results support PRP or ranibizumab for proliferative diabetic retinopathy  Healio

VANCOUVER, British Columbia — The 5-year outcomes from the DRCR.net Protocol S study support the use of either ranibizumab or panretinal ...

New algorithm can detect key marker of diabetic retinopathy with an accuracy of 98%  AOP

Brazilian and Australian researchers develop artificial intelligence technology that can spot fluid from damaged blood vessels inside the retina.

Time in Range According to CGM Associated With Diabetic Retinopathy  Endocrinology Advisor

Investigators assessed the time in range according to a continuous glucose monitor and the risk for diabetic retinopathy.

Comparing of Atara Biotherapeutics Inc. (ATRA) and Kodiak Sciences Inc. (NASDAQ:KOD)  The Hi New Ulm

As Biotechnology companies, Atara Biotherapeutics Inc. (NASDAQ:ATRA) and Kodiak Sciences Inc. (NASDAQ:KOD) are our subject to compare. And more ...

Google develops AI model that can detect diabetic retinopathy accurately  Economic Times

SAN FRANCISCO: Google has developed an Artificial Intelligence (AI) model that can detect diabetic retinopathy with a level of accuracy on par with human ...

The cloud-based tech that uses AI in medical diagnosis for adults with diabetes  Compelo

The IDx-DR uses artificial intelligence in medical diagnosis for eye diseases - meaning eye professionals don't need to be present to explain the images or ...

Diabetic Retinopathy: Reality and Risk of Loss to Follow-up  Medscape

Clinical studies on the treatments for diabetic retinopathy have focused on efficacy and safety, but the loss of patients to follow-up is a challenge that may be ...

AI system can detect diabetic retinopathy  UPI.com

Researchers developed a system that uses artificial intelligence to successfully detect diabetic retinopathy, according to a trial in primary care offices.

» Load more

What about Resources?

Dr. Pautler's Blog

This site is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. Through this site and linkages to other sites, The information provided in this site, or through linkages to other sites, is not a substitute for medical or professional care, and you should not use the information in place of a visit, call consultation or the advice of your physician or other healthcare provider.

IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY, YOU SHOULD IMMEDIATELY CALL 911 OR YOUR PHYSICIAN. If you believe you have any other health problem, or if you have any questions regarding your health or a medical condition, you should promptly consult your physician or other healthcare provider. Never disregard medical or professional advice, or delay seeking it, because of something you read on this site or a linked website. Never rely on information on this website in place of seeking professional medical advice. You should also ask your physician or other healthcare provider to assist you in interpreting any information in this Site or in the linked websites, or in applying the information to your individual case.

Medical information changes constantly. Therefore the information on this Site or on the linked websites should not be considered current, complete or exhaustive, nor should you rely on such information to recommend a course of treatment for you or any other individual. Reliance on any information provided on this Site or any linked websites is solely at your own risk.